Metagenics®
Ostera™
Promotes Healthy Bone Remodeling in Postmenopausal Women
Recommendations: Take one tablet twice
daily, or as directed by your healthcare practitioner.
Size: 60 Tablet Bottle
Product
Description: Ostera,
in combination with a Mediterranean-style, low-glycemic-load diet and
aerobic exercise, has been clinically shown in postmenopausal women to
beneficially influence key biomarkers of bone remodeling more than diet
and exercise alone.
- Features berberine and
selective kinase response modulators (SKRMs) derived from hops—reduced
iso-alpha acids (RIAA)—which target metabolic processes related to
bone health.
- Provides Vitamin K, a
key vitamin in the metabolism of bone proteins crucial to bone
integrity.
- Supplies Vitamin D,
associated with bone formation and bone mineralization.
- All-natural formula
without serious adverse effects.
|
EACH TABLET SUPPLIES: |
|
Vitamin D (as
cholecalciferol) |
500
IU |
|
Vitamin K (as
phytonadione) |
500
mcg |
|
Berberine HCl (Phellodendron
amurense bark extract) |
90
mg |
|
Reduced Iso-Alpha
Acids Complex |
370
mg |
|
(from hops extract,
Humulus lupulus L.) |
|
Other Ingredients:
Microcrystalline cellulose, stearic acid, croscarmellose sodium,
calcium silicate, silica, magnesium stearate, and coating (deionized
water, microcrystalline cellulose, polyethylene glycol, and
carrageenan).
|
Warning:
Do not use if pregnant, nursing, or if taking cyclosporine or
anticoagulant medication.
|
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat cure,
or prevent any diseases.
All product names listed are
trademarks of Metagenics, Inc. and are used with permission.
This website is not
sponsored by Metagenics, Inc. and it is not affiliated with Metagenics,
Inc. |
